| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/10/1999 | CN1207683A Cytokine and Hemopoietic factor endogenous production enhancer and method of use thereof |
| 02/10/1999 | CN1207681A Sustained-release microgranules contg. diltiazem as active principle |
| 02/10/1999 | CN1207673A Endoparasiticidal agents |
| 02/10/1999 | CN1207672A Modified release oral pharmaceutical composition contg. 5-ASA and method for treatment of bowel diseases |
| 02/10/1999 | CN1207292A Stable anti-racemic medicinal preparation of cilancetlone |
| 02/09/1999 | WO1999043736A1 Carrier polymers migrating into target organs and drug-containing polymers |
| 02/09/1999 | US5869715 Cationic monoamine compound (quaternary ammonium or tertiary amine salt with 2 halogenated aliphatic groups and 2 ethers or esters) for transporting biologically active species through membrane barriers; nonviral |
| 02/09/1999 | US5869711 Ceramide compounds, process for their preparation and use |
| 02/09/1999 | US5869602 Glucagon having lipophilic substituent on epsilon-amino group of lysine in position 30 |
| 02/09/1999 | US5869466 Vitamin B12 mediated oral delivery systems for GCSF |
| 02/09/1999 | US5869337 Regulated transcription of targeted genes and other biological events |
| 02/09/1999 | US5869331 Target cell specific chimeric spleen necrosis virus viral particles having antigenic binding and natural viral proteins; gene therapy |
| 02/09/1999 | US5869306 Gene transfer preparation |
| 02/09/1999 | US5869248 Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences |
| 02/09/1999 | US5869103 Blend of a biodegradable polymer and water soluble polymer improves loading and gives a linear release profile of biologically active agents such as peptides, dna and proteins |
| 02/09/1999 | US5869102 Solid pharmaceutical compositions containing (S)-2-(4-isobutylphenyl) propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
| 02/09/1999 | US5869101 Process for the preparation of S(+)-ibuprofen-particles |
| 02/09/1999 | US5869098 Includes at least one flowable, partially crystallized amorphous matrix comprising carbohydrate(s) and sugar alcohol(s) and a tableting aid with a bio-affecting agent |
| 02/09/1999 | US5869094 Solid form of administration of isosorbide 5-mononitrate |
| 02/09/1999 | US5869091 Aqueous vehicle, vesicle comprising nonionic surfactant, sterol and charged species suspended in aqueous vehicle and pharmaceutically active agent in both vesicle and aqueous vehicle |
| 02/09/1999 | US5869088 Preparation containing fatty acid, fatty acid ester or alcohol as absorption enhancer |
| 02/09/1999 | US5869087 Patch having a preparation for external use attached thereto |
| 02/09/1999 | US5869086 Systems for the controlled release of pilocarpine |
| 02/09/1999 | US5869079 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 02/09/1999 | US5869077 Subcutaneously implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete insulin dispersed in biocompatible matrix, surrounded by biocompatible external permselective jacket |
| 02/09/1999 | US5869051 Conjugated terthiophene and furan compounds with photoenhanced biocidal properties |
| 02/09/1999 | US5869045 Polypeptide comprising antigen-binding region of monoclonal antibody produced by specified hybridoma |
| 02/09/1999 | US5869034 Use of sphingolipids in the preparation of a cosmetic or dermopharmaceutical composition protecting the skin and hair against the harmful effects of atmospheric pollution |
| 02/09/1999 | US5868824 Inorganically filled, starch-based compositions for manufacturing containers and other articles having a thermodynamically controlled cellular matrix |
| 02/09/1999 | CA2226091C Cyclosporin-containing soft capsule preparations |
| 02/04/1999 | WO1999005302A1 Conjugates of transporter peptides and nucleic acid analogs, and their use |
| 02/04/1999 | WO1999005183A1 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy |
| 02/04/1999 | WO1999005094A1 Novel compositions for the delivery of negatively charged molecules |
| 02/04/1999 | WO1999004824A1 Polymer based pharmaceutical compositions for targeted delivery of biologically active agents |
| 02/04/1999 | WO1999004823A1 Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles |
| 02/04/1999 | WO1999004822A2 New salts with beneficial organoleptic properties |
| 02/04/1999 | WO1999004821A2 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 02/04/1999 | WO1999004820A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 02/04/1999 | WO1999004819A1 Liposomal compositions for the delivery of nucleic acid catalysts |
| 02/04/1999 | WO1999004818A1 Preparation composition and process for producing the same |
| 02/04/1999 | WO1999004813A1 Receptor specific transepithelial transport of therapeutics |
| 02/04/1999 | WO1999004799A1 Fatty emulsions containing reducing sugar and method for sterilizing the same |
| 02/04/1999 | WO1999004798A1 Lyophilized fosphenytoin sodium for parenteral use |
| 02/04/1999 | WO1999004790A1 Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative |
| 02/04/1999 | WO1999004788A1 Aqueous compositions comprising ranitidine and lcmt sucrose |
| 02/04/1999 | WO1999004787A1 Taxol emulsion |
| 02/04/1999 | WO1999004779A1 Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin |
| 02/04/1999 | WO1999004765A2 Pharmaceutical compositions containing an effervescent acid-base couple |
| 02/04/1999 | WO1999004764A1 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity |
| 02/04/1999 | WO1999004763A1 Improved multiparticulate tablet with quick disintegration |
| 02/04/1999 | WO1999004760A1 Spherical single-substance particles, medicines and foodstuffs containing the particles, and method of production thereof |
| 02/04/1999 | WO1999004758A1 A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets |
| 02/04/1999 | WO1998049182A3 Gggg or gtgt as carriers for drug delivery |
| 02/04/1999 | DE19811402A1 Preparation of medicaments for treatment of tumours |
| 02/04/1999 | DE19734544A1 Schellackhaltiges kosmetisches Produkt Shellac-containing cosmetic product |
| 02/04/1999 | DE19733505A1 Schnell wirksames Analgeticum Fast-acting analgesic |
| 02/04/1999 | DE19733094A1 Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität Formulation based on ascorbic acid with improved color stability |
| 02/04/1999 | DE19732903A1 Pellet-Formulierung zur Behandlung des Intestinaltraktes The pellet formulation for the treatment of the intestinal tract |
| 02/04/1999 | CA2301166A1 Liposomal compositions for the delivery of nucleic acid catalysts |
| 02/04/1999 | CA2300695A1 Novel compositions for the delivery of negatively charged molecules |
| 02/04/1999 | CA2298067A1 Conjugates of transporter peptides and nucleic acid analogs, and their use |
| 02/04/1999 | CA2298065A1 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 02/04/1999 | CA2297487A1 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy |
| 02/04/1999 | CA2297025A1 Polymer based pharmaceutical compositions for targeted delivery of biologically active agents |
| 02/04/1999 | CA2296798A1 Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents |
| 02/04/1999 | CA2296654A1 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity |
| 02/04/1999 | CA2296562A1 Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative |
| 02/04/1999 | CA2295037A1 Aqueous compositions comprising ranitidine and lcmt sucrose |
| 02/04/1999 | CA2212300A1 In vitro or in vivo gelfying chitosan and therapeutic uses thereof |
| 02/03/1999 | EP0894807A1 GPIb-LIPID COMPLEX AND USES THEREOF |
| 02/03/1999 | EP0894767A1 Silicon oxide containing solid of high specific surface |
| 02/03/1999 | EP0894495A1 Bioadhesive embossed tablets |
| 02/03/1999 | EP0894128A1 Conjugation of polypeptides |
| 02/03/1999 | EP0894043A1 Method of forming articles and patterning surfaces via capillary micromolding |
| 02/03/1999 | EP0894011A2 Delivery of nucleic acids by porphyrins |
| 02/03/1999 | EP0894010A2 Denaturants for sympathomimetic amine salts |
| 02/03/1999 | EP0893998A1 Colonic delivery of nicotine to treat inflammatory bowel disease |
| 02/03/1999 | EP0893994A2 Diclofenac/gamma-cyclodextrin inclusion compounds |
| 02/03/1999 | EP0893992A2 Fast disintegrating oral dosage form |
| 02/03/1999 | EP0893990A1 Ophthalmological composition of the type which undergoes liquid-gel phase transition |
| 02/03/1999 | EP0649274B1 Aqueous compositions comprising an organic peroxiacid |
| 02/03/1999 | EP0510186B1 Therapeutic uses of melanin |
| 02/03/1999 | CN1207047A Cartilage/bone inducing materials for reparation |
| 02/03/1999 | CN1207044A Cyclosporin-containing soft capsule preparations |
| 02/03/1999 | CN1207036A Granulates for cosmetic and pharmaceutical preparations |
| 02/03/1999 | CN1207035A Composition base for topical therapeutic and cosmetic preparations |
| 02/02/1999 | US5866679 Peptides |
| 02/02/1999 | US5866590 Ascorbic acid or a-tocopherol and ascorbyl palmitate as oxidative stabilizers |
| 02/02/1999 | US5866538 Stability; mixture with glycerol and(or) mannitol |
| 02/02/1999 | US5866536 Compounds and compositions for delivering active agents |
| 02/02/1999 | US5866434 Containing fullerenes |
| 02/02/1999 | US5866351 CD4+ T-lymphocyte proteases and genes encoding said proteases |
| 02/02/1999 | US5866179 Containing cyclodextrin complex |
| 02/02/1999 | US5866166 Blend of microcrystalline cellulose and compressibility adjuvant |
| 02/02/1999 | US5866162 Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple |
| 02/02/1999 | US5866159 Pharmaceutical compositions comprising cyclosporins |
| 02/02/1999 | US5866157 Matrix patch formulation |
| 02/02/1999 | US5866154 Parenteral drug autoclaved for sterilization |
| 02/02/1999 | US5866132 Immunogenic oligosaccharide compositions |
| 02/02/1999 | US5866129 Method of producing an antibody with a peptide corresponding to membrane-bound IgA |